This has reference to our letter dated April 26, 2025, The Board of Directors of the Company at their meeting held on May 07, 2025 have resolved as follows: Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith the following: a) Audited Financial Results (Standalone and Consolidated) of the Company for the fourth quarter and financial year ended March 31, 2025. b) Report of the Auditors on the Audited Financial Results, both for Standalone and Consolidated financial statements for the financial year ended March 31, 2025. c) Declaration pursuant to Regulation 33(3)(d) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for Consolidated and Standalone Financial Statements for the Financial Year ended March 31, 2025. The meeting of the Board of Directors of the Company commenced at 11.00 AM and concluded at 03.30 PM.

pdf

Transgene Biotek Ltd.

26 Apr 2025

3.69

-7.98%

Board Meeting

Transgene Biotek Ltd - 526139 - Board Meeting Intimation for Intimation Of The Board Meeting Of …

BSE India

Transgene Biotek Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/05/2025 ,inter alia, to consider and approve 1) To Consider and approve the Audited Financial Results (Standalone and consolidated) of the Company for the fourth quarter and financial year ended March 31, 2025. 2) Any Other Business matter, with the permission of the Chair.

pdf

Transgene Biotek Ltd.

26 Apr 2025

3.69

-7.98%

Corp. Note

Transgene Biotek Ltd - 526139 - Compliance-57 (5) : intimation after the end of quarter

BSE India

Non-Applicability of Reg. 57(5) of SEBI (LODR) Regulations, 2015.

pdf

Transgene Biotek Ltd.

24 Apr 2025

3.69

-7.98%

Company Update

Transgene Biotek Ltd - 526139 - We Are Enclosing Hereto The Compliance Certificate As Per Clause …

BSE India

Compliance Certificate Clause 40(9)

pdf

Transgene Biotek Ltd.

19 Apr 2025

3.69

-7.98%

Company Update

Transgene Biotek Ltd - 526139 - Statement Of Deviation & Variation

BSE India

Statement of Deviation & Variation

pdf

Transgene Biotek Ltd.

19 Apr 2025

3.69

-7.98%

Company Update

Transgene Biotek Ltd - 526139 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Compliances Certificate under Reg. 74(5).

pdf

Transgene Biotek Ltd.

19 Apr 2025

3.69

-7.98%

Corp. Note

Transgene Biotek Ltd - 526139 - Format of the Initial Disclosure to be made by an …

BSE India

Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyTransgene Biotek Ltd 2CIN NO.L85195TG1990PLC011065 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.00 4Highest Credit Rating during the previous FY 0 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: ANKITA JAIN Designation: COMPANY SECRETARY and Compliance Officer EmailId: j.ankita0025@gmail.com Name of the Chief Financial Officer: PRASAD CHOWDARI Designation: CFO EmailId: accounts@transgenebiotek.com Date: 19/04/2025 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.

pdf

Is Transgene Biotek Ltd. worth buying?

69 Votes:

Buy 92.75%

Sell 5.8%

Hold 1.45%

56.94% Fall from 52W High

High volume+loss today

Transgene Biotek Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Transgene Biotek Ltd. on BSE